Global Medical REIT Inc. Prices 8% Series B Preferred Stock Offering, Raising $50 Million

GMRE
November 14, 2025

Global Medical REIT Inc. (GMRE) priced a public offering of 2,000,000 shares of its 8.00% Series B cumulative redeemable preferred stock on November 14, 2025. Each share carries a $0.001 par value and an initial liquidation preference of $25.00 per share, and the company expects gross proceeds of approximately $50 million before underwriting discounts and commissions.

The net proceeds will be directed toward general corporate purposes, including funding new acquisitions and repaying indebtedness under its existing credit facility. By raising capital through preferred stock rather than common equity, GMRE can strengthen its balance sheet while preserving ownership concentration for existing shareholders.

The Series B preferred shares will be listed on the New York Stock Exchange under the symbol ‘GMRE PrB’. The 8% dividend rate is competitive in the current REIT environment, where investors seek stable income streams amid fluctuating interest rates. The cumulative and redeemable features provide investors with a safety net and give GMRE flexibility to repurchase the shares at a predetermined price after a specified date.

Underwriting terms are expected to reduce the gross proceeds by a typical discount and commission structure for preferred offerings, though the exact net amount has not yet been disclosed. The company’s management has indicated that the capital raise will support its growth strategy and help maintain a strong debt‑to‑equity profile in a market where refinancing costs can be high.

Management emphasized that the preferred stock issuance is part of a broader plan to accelerate portfolio expansion in the healthcare real‑estate sector while simultaneously reducing leverage. The move is intended to position GMRE for opportunistic acquisitions and to provide a buffer against potential interest‑rate volatility that could impact future debt servicing costs.

The offering underscores GMRE’s commitment to delivering long‑term value to investors through disciplined capital allocation and strategic growth initiatives, while maintaining a robust balance sheet that can weather market fluctuations.

The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.